Erratum: Programs for the persistence, vigilance and control of human CD8

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Tissue-resident memory T cells and lung immunopathology.Immunological reviews · 2023
   Review
2. Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells.Cancer cell · 2022
   Article
3. Cellular interactions in resident memory T cell establishment and function.Current opinion in immunology · 2022
   Review
4. Inflammatory signals are sufficient to elicit TOX expression in mouse and human CD8+ T cells.JCI insight · 2021
   Article
5. The Roles of Tissue-Resident Memory T Cells in Lung Diseases.Frontiers in immunology · 2021
   Review
6. Systemic and respiratory T-cells induced by seasonal H1N1 influenza protect against pandemic H2N2 in ferrets.Communications biology · 2020
   Article

Corrections and comments

• Erratum for
  Programs for the persistence, vigilance and control of human CD82016

Authors and funding

15 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.